Literature DB >> 1331177

Interleukin-2 and interleukin-2 receptor expression in human corticotrophic adenoma and murine pituitary cell cultures.

E Arzt1, G Stelzer, U Renner, M Lange, O A Müller, G K Stalla.   

Abstract

The production of IL-1 and IL-6 by pituitary cells has recently been demonstrated. In this study we investigated the expression of IL-2 and its receptor (IL-2R) by pituitary cells of different species. In Northern blots, a single hybridizing band of 1 kb, identical to that in normal stimulated lymphocytes, was obtained with specific IL-2 probes. In the mouse AT-20 pituitary tumor cell line, IL-2 mRNA expression was detected after stimulation with corticotropin-releasing hormone or phorbol myristate acetate. In human corticotrophic adenoma cells, basal IL-2 mRNA expression as well as IL-2 secretion were further stimulated by phorbol myristate acetate. Both adenoma and AtT-20 cells showed detectable amounts of IL-2R mRNA and by immunofluorescence, IL-2R membrane expression. In addition, dual immunofluorescence studies in rat anterior pituitary cells demonstrated colocalization of IL-2R with ACTH-positive cells and other cell types expressing the receptor. In addition to the action of lymphocyte-produced IL-2, this cytokine may have a paracrine or autocrine regulatory role within the pituitary. It remains to be established whether IL-2 production occurs in the normal pituitary or is intrinsic to the process of tumor development of these cells. IL-2 may be involved in the growth control of pituitary cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331177      PMCID: PMC443256          DOI: 10.1172/JCI116072

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  Interleukin-1 stimulates interleukin-6 release from rat anterior pituitary cells in vitro.

Authors:  B L Spangelo; A M Judd; P C Isakson; R M MacLeod
Journal:  Endocrinology       Date:  1991-06       Impact factor: 4.736

2.  Localization of interleukin-1 receptor messenger RNA in murine hippocampus.

Authors:  E T Cunningham; E Wada; D B Carter; D E Tracey; J F Battey; E B De Souza
Journal:  Endocrinology       Date:  1991-05       Impact factor: 4.736

3.  Lesions of the medial septal nucleus produce a long-lasting inhibition of T lymphocyte proliferation.

Authors:  M Labeur; V E Nahmod; S Finkielman; E Arzt
Journal:  Neurosci Lett       Date:  1991-04-29       Impact factor: 3.046

4.  Interleukin 6 possibly induced by interleukin 1 beta in the pituitary gland stimulates the release of gonadotropins and prolactin.

Authors:  M Yamaguchi; N Matsuzaki; K Hirota; A Miyake; O Tanizawa
Journal:  Acta Endocrinol (Copenh)       Date:  1990-02

5.  Temperature-dependent modulation of lipopolysaccharide-induced interleukin-1 beta and tumor necrosis factor alpha expression in cultured human astroglial cells by dexamethasone and indomethacin.

Authors:  S Velasco; M Tarlow; K Olsen; J W Shay; G H McCracken; P D Nisen
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

6.  Interleukin-1 receptors in mouse brain: characterization and neuronal localization.

Authors:  T Takao; D E Tracey; W M Mitchell; E B De Souza
Journal:  Endocrinology       Date:  1990-12       Impact factor: 4.736

7.  Production of interleukin-6 by anterior pituitary cells in vitro.

Authors:  B L Spangelo; R M MacLeod; P C Isakson
Journal:  Endocrinology       Date:  1990-01       Impact factor: 4.736

Review 8.  Cytokines and the hypothalamic-pituitary-adrenal axis.

Authors:  A R Hermus; C G Sweep
Journal:  J Steroid Biochem Mol Biol       Date:  1990-12-20       Impact factor: 4.292

9.  Interleukin-6 secreting human pituitary adenomas in vitro.

Authors:  T H Jones; S Justice; A Price; K Chapman
Journal:  J Clin Endocrinol Metab       Date:  1991-07       Impact factor: 5.958

10.  Endotoxin-induced release of interleukin-6 from rat medial basal hypothalami.

Authors:  B L Spangelo; A M Judd; R M MacLeod; D W Goodman; P C Isakson
Journal:  Endocrinology       Date:  1990-10       Impact factor: 4.736

View more
  13 in total

1.  Genes expressed in the mouse pituitary corticotrope AtT-20/D-16v tumor cell line.

Authors:  M R Schiller
Journal:  Pituitary       Date:  2000-11       Impact factor: 4.107

2.  Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.

Authors:  D W Ray; S G Ren; S Melmed
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

3.  Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretion.

Authors:  I Shimon; X Yan; D W Ray; S Melmed
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

4.  TRH receptor on immune cells: in vitro and in vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis by TRH.

Authors:  S Raiden; E Polack; V Nahmod; M Labeur; F Holsboer; E Arzt
Journal:  J Clin Immunol       Date:  1995-09       Impact factor: 8.317

Review 5.  Cytokines as mediators in the regulation of the hypothalamic-pituitary-adrenocortical function.

Authors:  J Fukata; H Imura; K Nakao
Journal:  J Endocrinol Invest       Date:  1994-02       Impact factor: 4.256

Review 6.  Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.

Authors:  Marni N Silverman; Brad D Pearce; Christine A Biron; Andrew H Miller
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

7.  Retinoic acid prevents experimental Cushing syndrome.

Authors:  M Páez-Pereda; D Kovalovsky; U Hopfner; M Theodoropoulou; U Pagotto; E Uhl; M Losa; J Stalla; Y Grübler; C Missale; E Arzt; G K Stalla
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

8.  Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis.

Authors:  M Costas; T Trapp; M P Pereda; J Sauer; R Rupprecht; V E Nahmod; J M Reul; F Holsboer; E Arzt
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

9.  Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk.

Authors:  Marcelo Paez-Pereda; Damiana Giacomini; Damian Refojo; Alberto Carbia Nagashima; Ursula Hopfner; Yvonne Grubler; Alberto Chervin; Victoria Goldberg; Rodolfo Goya; Shane T Hentges; Malcolm J Low; Florian Holsboer; Gunter K Stalla; Eduardo Arzt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

10.  Increased proliferation of a human breast carcinoma cell line by recombinant interleukin-2.

Authors:  M Katano; T Matsuo; T Morisaki; K Naito; F Nagumo; E Kubota; M Nakamura; T Hisatsugu; J Tadano
Journal:  Cancer Immunol Immunother       Date:  1994-09       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.